
Weight-loss offering combining oral or injectable GLP-1 prescribing with nutrition-first care and a provider-led deprescription pathway.
Virta for Weight Loss+ combines medication prescribing with personalized nutrition and lifestyle support. Members can receive clinical oversight during treatment and a provider-led medication off-ramp when appropriate, bringing prescription management and behavioral care into one service.
Virta's April 2025 announcement reported approximately five percent average weight loss after 90 days in its Responsible Prescribing program. Its broader weight-loss portfolio also includes nutrition-only treatment, and the provider reported that fewer than one quarter of those portfolio members were using GLP-1s.
Virta's prescribing track serves organizations that include GLP-1 access in their benefits strategy. The provider's June 2025 announcement describes employers and health plans restricting or discontinuing obesity-drug coverage as costs increase, which can limit members' access to medication-inclusive care.
The program's performance guarantees also have enrollment and measurement requirements. Virta's buyer page specifies at least 300 members enrolled for more than six months and defined measurement periods, so purchasers must assess those conditions against their covered population.
Virta Health built its clinical model on nutrition therapy for diabetes reversal before extending it to weight loss, and the company describes more than a decade of nutrition-first care. The weight-loss line was introduced as a distinct offer alongside the company's diabetes programs.
Virta for Weight Loss+ was introduced as the medication-inclusive track, adding GLP-1 prescribing to the nutrition-only offering. Virta subsequently expanded GLP-1 fulfillment to pharmacy benefit manager, direct-to-employer, and direct-to-consumer pathways and added cost and outcome guarantees to the weight-loss programs.
Employer and health plan spending on GLP-1 medications for weight loss has risen sharply, and Virta's material frames the category as one where organizations struggle to balance member demand against pharmacy cost. Virta reports that hundreds of large self-insured employers have adopted its programs.
Buyer interest is shifting toward arrangements that tie payment to documented outcomes, a structure Virta has built into this offering through utilization and return-on-investment guarantees. Virta also points to growing member interest in oral GLP-1 therapies, which widens the population that programs pairing medication with clinical support can serve.
Virta for Weight Loss+ is a weight management service that combines GLP-1 medication prescribing with nutrition-first clinical care for members of employer and health plan sponsors. Virta's clinical team manages prescriptions and supports members through personalized nutrition coaching delivered in the company's app.
It sits alongside Virta for Weight Loss, the company's nutrition-only track, on one shared buyer page. Virta positions the program for organizations seeking to contain weight-loss medication spending while still offering medication access to members who need it.